Bank of New York Mellon Corp - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 1 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$19,000
+26.7%
140,620
-3.0%
0.00%
Q4 2018$15,000
-54.5%
144,9060.0%0.00%
Q3 2018$33,0000.0%144,906
-0.0%
0.00%
Q2 2018$33,000
-54.2%
144,907
-28.2%
0.00%
Q1 2018$72,000
+22.0%
201,753
+23.7%
0.00%
Q4 2017$59,000
-1.7%
163,092
+12.5%
0.00%
Q3 2017$60,000
-25.0%
144,907
-7.5%
0.00%
Q2 2017$80,000
-11.1%
156,677
+0.8%
0.00%
Q1 2017$90,000
-2.2%
155,496
+7.3%
0.00%
Q4 2016$92,000
-35.2%
144,906
-6.9%
0.00%
Q3 2016$142,000
+47.9%
155,666
-13.8%
0.00%
Q2 2016$96,000
-82.7%
180,655
-69.3%
0.00%
Q1 2016$555,000
-30.5%
587,559
-2.0%
0.00%
Q4 2015$798,000
-41.4%
599,648
+0.5%
0.00%
Q3 2015$1,361,000
+17.4%
596,640
-17.1%
0.00%
Q2 2015$1,159,000
+7.9%
719,692
+6.6%
0.00%
Q1 2015$1,074,000
-23.4%
674,868
-9.1%
0.00%
Q4 2014$1,403,000
+38.6%
742,459
-3.2%
0.00%
Q3 2014$1,012,000
-48.4%
767,306
-42.0%
0.00%
Q2 2014$1,960,000
+73.8%
1,323,350
+117.0%
0.00%
Q1 2014$1,128,000
-15.5%
609,884
-5.4%
0.00%
Q4 2013$1,335,000
-61.0%
644,695
-50.1%
0.00%
-100.0%
Q3 2013$3,422,000
+102.0%
1,290,698
+103.5%
0.00%0.0%
Q2 2013$1,694,000634,3480.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q2 2019
NameSharesValueWeighting ↓
Platinum Management (NY) LLC 10,375,329$13,549,00019.76%
Catalyst Capital Advisors LLC 790,000$1,635,0000.53%
DSC Advisors, L.P. 500,000$1,035,0000.50%
STONERIDGE INVESTMENT PARTNERS LLC 142,528$295,0000.06%
Hudock, Inc. 30,500$63,0000.05%
BRR OpCo, LLC 52,700$109,0000.05%
TFS CAPITAL LLC 418,074$865,0000.04%
LifePlan Financial Group, Inc 28,810$60,0000.04%
NOMURA HOLDINGS INC 3,831,177$7,947,0000.04%
BOLTON LP 77,400$160,0000.03%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders